Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine and citalopram pharmacological resting-state fMRI study in aging and dementia
NL-OMON37710Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Jul 2012
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Alzheimer's disease (AD), frontotemporal dementia (FTD) and dementia with Lewy bodies (DLB) comparing Galantamine challenge, Citalopram challenge and Placebo (3 arms). Primary endpoint: Resting-state network activity. Started Jul 2012; status: active, not recruiting.
02
Drugs
galantaminecitalopram
03
Conditions
Alzheimer's disease (AD)frontotemporal dementia (FTD)dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NL-OMON37710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37710.